MK0462-083 AM1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK0462-083 AM1, covering 2009-09-02 to 2009-09-02. Get the full timeline:
Most recent: Clinical Trial Update: Drug Study in Pediatric Subjects With Migraines (MK0462-083 AM1) [Phase 1]